Every microsampling success story is based on unique objectives. Your Microsampling Specialist will be with you every step of the way and help you develop a winning strategy to make the most of this transformative dried blood collection technology.
Along with personalized guidance, you'll have access to our methods and protocols, detailed case studies and resources to help you successfully develop methods for your analytes of interest. Your Microsampling Specialist will be there to address your concerns and questions, as they arise.
After you review your study data with your Microsampling Specialist, you'll define your objectives for a full bioanalytical and clinical validation. This is also the time to loop in key stakeholders. We'll see you through the challenge and triumph of implementing this smarter, simpler, blood collection technology company-wide.
You're about to take your first step toward a future of better blood collection.
When we receive your information, our experts will contact you to review your evaluation objectives and get you started in the way that makes sense for you and with the Mitra® format that meets your needs.
© Neoteryx 2021 | Privacy Policy | Sitemap
421 Amapola Ave
Torrance, CA 90501
This site is protected by reCAPTCHA and the Google Privacy
Policy and Terms of Service apply.
Mitra devices are intended as a specimen collector and for the storage and transport of biological fluids. They are CE-IVD self-certified in the UK and EU, a Class 1 IVD in Australia & China, Class B in South Africa, and registered with health agencies in Canada, Thailand, and Ukraine. In the United States, Mitra devices are for Research Use Only (RUO). In some countries, Mitra devices may be used in clinical diagnostic laboratory systems after the laboratory has validated their complete system in compliance with relevant rules and regulations. Neoteryx operates a Quality Management System (QMS) that is based on FDA good manufacturing practices, 21 CFR 820 regulations, and ISO-13485.